Skip to main content
Venous 2025 Main banner
Final Program


Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back

Judith C. Lin, MD MBA

Professor and Chief of Vascular Surgery
Michigan State University of Human Medicine
EAST LANSING, Michigan, United States

Dr. Judith Lin is a Professor and Chief of Vascular Surgery in the Department of Surgery at Michigan State University College of Human Medicine and Section Chief of Cardiovascular Thoracic Surgery at McLaren Greater Lansing Hospital in Lansing, Michigan. She is a distinguished fellow of the Society for Vascular Surgery (SVS), Vice Chair of SVS Clinical Practice Council, Fellow of the Executive Leadership in Academic Medicine, Treasurer of Michigan Vascular Society, and a board examiner for the American Board of Surgery (ABS) Vascular Surgery Qualifying and Certifying Examination

She is an M.D. graduate of New York University School of Medicine in 1997 and completed the Executive MBA program at the University of Michigan Ross School of Business in 2017. After her surgical residency at Mount Sinai Hospital in 2002, she obtained her vascular surgery fellowship training at Tufts-New England Medical Center in 2004. She was awarded the 2004 Marco Polo Traveling Scholarship from the SVS for additional training in Germany in advanced Minimally Invasive Vascular Surgery. She also received the 2011 Peripheral Vascular Surgery Society traveling award for professional development on robotic aortic surgery in the Czech Republic.

Board-certified by the ABS in General Surgery and Vascular Surgery, Dr. Lin has been elected to the Fellowship of the American College of Surgeons (ACS) and a distinguished fellow of the SVS. She has been selected as one of the Top Docs in General Vascular Surgery by Detroit HOUR Magazine 13 times, one of America’s Top Surgeons by Consumers’ Research Council of America, and a Castle Connelly America’s Top Doctors in Vascular Surgery 7 times. Her professional interests include minimally invasive vascular surgery such as endovascular and robotic-assisted vascular surgery, percutaneous peripheral intervention, complex venous disease, and telemedicine as well as healthcare administration with a focus on value-based health care.

Disclosure information not submitted.

Presentation(s):